Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FALTA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,489
Award facts
- Contract value 100% obligated
- $38,488.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $38,488.56 delivery order to Amerisourcebergen Drug Corp on April 23, 2026, for Dupixent 300 mg/2 ml pen injectables, with ultimate completion on April 24, 2026.
The order is issued under a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to military healthcare systems. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26FALTA?
SPE2DR26FALTA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 23, 2026.
How much is contract SPE2DR26FALTA worth?
The government has obligated $38,489 on SPE2DR26FALTA.
Is contract SPE2DR26FALTA an order under another contract?
Yes. SPE2DR26FALTA is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FALTA competed?
The extent of competition for SPE2DR26FALTA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award